Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan in Cirrhosis Ascites
NCT01349348Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in ascites, Liver cirrhosis (LC), sponsored by Otsuka Holdings. Started Oct 2010; status: completed.
02
Drugs
tolvaptan
03
Conditions
ascitesLiver cirrhosis (LC)
Beyond the preview
Go deeper on NCT01349348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349348.